Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine

Identifieur interne : 000163 ( Main/Exploration ); précédent : 000162; suivant : 000164

Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine

Auteurs : RBID : ISTEX:259_1994_Article_BF00285590.pdf

English descriptors

Abstract

Systemic administration of lysine to mice injected with indium-111-labelled Fab fragment of a monoclonal antibody has been shown to reduce renal uptake/retention of the radiometal. This treatment should be applicable to clinical immunoscintigraphy and radioimmunotherapy with radiometal-labelled antibody fragments.

DOI: 10.1007/BF00285590

Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title>Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine</title>
<author>
<name>M. V. Pimm</name>
<affiliation wicri:level="1">
<mods:affiliation>Cancer Research Laboratories, University of Nottingham, NG7 2RD, Nottingham, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cancer Research Laboratories, University of Nottingham, NG7 2RD, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
<author>
<name>S. J. Gribben</name>
<affiliation wicri:level="1">
<mods:affiliation>Cancer Research Laboratories, University of Nottingham, NG7 2RD, Nottingham, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cancer Research Laboratories, University of Nottingham, NG7 2RD, Nottingham</wicri:regionArea>
<wicri:noRegion>Nottingham</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="RBID">ISTEX:259_1994_Article_BF00285590.pdf</idno>
<date when="1994">1994</date>
<idno type="doi">10.1007/BF00285590</idno>
<idno type="wicri:Area/Main/Corpus">000B28</idno>
<idno type="wicri:Area/Main/Curation">000B28</idno>
<idno type="wicri:Area/Main/Exploration">000163</idno>
</publicationStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino acid</term>
<term>Immunoscintigraphy</term>
<term>Radiometal</term>
<term>Renal uptake</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="eng">Systemic administration of lysine to mice injected with indium-111-labelled Fab fragment of a monoclonal antibody has been shown to reduce renal uptake/retention of the radiometal. This treatment should be applicable to clinical immunoscintigraphy and radioimmunotherapy with radiometal-labelled antibody fragments.</div>
</front>
</TEI>
<mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="c56962f1e236db33e7c5429997c4719b58a5173f">
<titleInfo lang="eng">
<title>Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine</title>
</titleInfo>
<name type="personal">
<namePart type="given">M. V.</namePart>
<namePart type="family">Pimm</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Cancer Research Laboratories, University of Nottingham, NG7 2RD, Nottingham, UK</affiliation>
</name>
<name type="personal">
<namePart type="given">S. J.</namePart>
<namePart type="family">Gribben</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Cancer Research Laboratories, University of Nottingham, NG7 2RD, Nottingham, UK</affiliation>
</name>
<typeOfResource>text</typeOfResource>
<genre>Short Communication</genre>
<genre>Brief Communication</genre>
<originInfo>
<publisher>Springer-Verlag, Berlin/Heidelberg</publisher>
<dateCreated encoding="w3cdtf">1994-03-08</dateCreated>
<dateValid encoding="w3cdtf">2004-08-14</dateValid>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="eng">Systemic administration of lysine to mice injected with indium-111-labelled Fab fragment of a monoclonal antibody has been shown to reduce renal uptake/retention of the radiometal. This treatment should be applicable to clinical immunoscintigraphy and radioimmunotherapy with radiometal-labelled antibody fragments.</abstract>
<subject lang="eng">
<genre>Key words</genre>
<topic>Immunoscintigraphy</topic>
<topic>Radiometal</topic>
<topic>Renal uptake</topic>
<topic>Amino acid</topic>
</subject>
<relatedItem type="series">
<titleInfo type="abbreviated">
<title>Eur J Nucl Med</title>
</titleInfo>
<titleInfo>
<title>European Journal of Nuclear Medicine</title>
<partNumber>Year: 1994</partNumber>
<partNumber>Volume: 21</partNumber>
<partNumber>Number: 7</partNumber>
</titleInfo>
<genre>Archive Journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">1994-07-01</dateIssued>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<subject usage="primary">
<topic>Medicine & Public Health</topic>
<topic>Imaging / Radiology</topic>
<topic>Nuclear Medicine</topic>
</subject>
<identifier type="issn">0340-6997</identifier>
<identifier type="issn">Electronic: 1619-7089</identifier>
<identifier type="matrixNumber">259</identifier>
<identifier type="local">IssueArticleCount: 27</identifier>
<recordInfo>
<recordOrigin>Springer-Verlag, 1994</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="doi">10.1007/BF00285590</identifier>
<identifier type="matrixNumber">Art12</identifier>
<identifier type="local">BF00285590</identifier>
<accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition>
<accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition>
<accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition>
<part>
<extent unit="pages">
<start>663</start>
<end>665</end>
</extent>
</part>
<recordInfo>
<recordOrigin>Springer-Verlag, 1994</recordOrigin>
<recordIdentifier>259_1994_Article_BF00285590.pdf</recordIdentifier>
</recordInfo>
</mods>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000163 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000163 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:259_1994_Article_BF00285590.pdf
   |texte=   Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine
}}

Wicri

This area was generated with Dilib version V0.5.81.
Data generation: Mon Aug 25 10:35:12 2014. Site generation: Thu Mar 7 10:08:40 2024